Unknown PHASE2 INTERVENTIONAL 1-arm NCT03641079

Identification of Compound From Brinjal Peel Extract in the Treatment of Palmar Arsenical Keratosis and Bowen's Disease

Identification of Compound From Brinjal Peel Extract That is Effective in the Treatment of Severe Palmar Arsenical Keratosis and Bowen's Disease

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Conditions Keratotic Nodular Size

Interventions Brinjal peel extract containing cream

Updated 5 times since 2018 Last updated: Aug 18, 2018 Started: Sep 16, 2017 Primary completion: Dec 31, 2018 Completion: Feb 28, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Keratotic Nodular Size and is currently ongoing. Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh leads this study, which shows 5 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
May 2020 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Sep 2018 — May 2020 [monthly]

Recruiting PHASE2

First recorded

Sep 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Data source: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bhanga, Bangladesh